Prednisolone (Orapred, Pred Forte, Pred Mild) — 2026 Medicare Part D coverage
prednisolone — sold as Orapred, Pred Forte, Pred Mild: 16 forms appear in Medicare Part D formularies for 2026. This page reports what plans filed with CMS; it does not recommend a plan.
Which plans in your county cover prednisolone?
Pick a county to see every Medicare Advantage plan filed there and every stand-alone Part D plan in its region, with this drug's tier, restrictions and tier cost sharing.
How to read drug coverage
Tier is the cost-sharing tier the plan assigned the drug in its CMS formulary filing; lower tiers usually cost less. PA = prior authorization, ST = step therapy (try another drug first), QL = quantity limit. Not on formulary means the plan did not list this exact form; the plan may cover another strength or a formulary exception may be possible. Cost sharing is the plan's initial-coverage amount for the tier as filed with CMS; the deductible, the $2,100 annual out-of-pocket cap, the $35 insulin cap and negotiated prices for selected drugs can change what you actually pay. Formularies change during the year; the plan's formulary document and Medicare.gov govern.
What the star rating under each Medicare Advantage plan means
What the star rating means. CMS rates every Medicare Advantage contract (the "H" number in the plan ID — all plans under it share the rating) on a 1-to-5 scale each October, from about 40 measures of care quality, member experience, complaints and appeals, customer service and, for plans with drug coverage, drug safety and pricing. The 2026 rating is largely based on performance measured in 2024.
5 Excellent4 Above average3 Average2 Below average1 Poor
Not rated means CMS published no overall rating — usually a contract too new to be measured or with too few members ("not enough data"); it is not a low score. A 5-star contract can be joined outside the normal enrollment windows (the 5-star Special Enrollment Period, Dec 8 – Nov 30). Medicare.gov flags contracts rated below 3 stars for three years running as low-performing. Stars describe the contract's past performance as CMS measured it; they are not a recommendation, and they do not tell you whether a plan's network, drugs or costs fit you.
Forms and strengths in 2026 formularies
| Form | Formularies listing it | Most common tier | PA | ST | QL |
|---|---|---|---|---|---|
| prednisoLONE acetate 1 % Ophthalmic Suspension generic · RxCUI 1376336 | 328 (100%) | 3 | 0 | 0 | 4 |
| prednisoLONE sodium phosphate 15 MG in 5 mL Oral Solution generic · RxCUI 283077 | 328 (100%) | 2 | 147 | 0 | 0 |
| prednisoLONE sodium phosphate 5 MG in 5 mL Oral Solution generic · RxCUI 312614 | 321 (98%) | 2 | 147 | 0 | 0 |
| prednisoLONE sodium phosphate 25 MG in 5 mL Oral Solution generic · RxCUI 249066 | 304 (93%) | 2 | 147 | 0 | 0 |
| prednisoLONE sodium phosphate 1 % Ophthalmic Solution generic · RxCUI 314165 | 259 (79%) | 3 | 0 | 0 | 1 |
| prednisoLONE sodium phosphate 20 MG in 5 mL Oral Solution generic · RxCUI 702306 | 45 (14%) | 2 | 10 | 0 | 0 |
| prednisoLONE sodium phosphate 10 MG in 5 mL Oral Solution generic · RxCUI 794979 | 34 (10%) | 2 | 10 | 0 | 0 |
| prednisoLONE 5 MG Oral Tablet generic · RxCUI 198142 | 23 (7%) | 2 | 6 | 0 | 0 |
| PRED MILD 0.12 % Ophthalmic Suspension brand · RxCUI 209002 | 19 (6%) | 4 | 0 | 0 | 0 |
| prednisoLONE sodium phosphate 15 MG Disintegrating Oral Tablet generic · RxCUI 643125 | 15 (5%) | 4 | 1 | 0 | 0 |
| prednisoLONE sodium phosphate 10 MG Disintegrating Oral Tablet generic · RxCUI 643123 | 14 (4%) | 4 | 1 | 0 | 0 |
| prednisoLONE sodium phosphate 30 MG Disintegrating Oral Tablet generic · RxCUI 643127 | 12 (4%) | 4 | 1 | 0 | 0 |
| Orapred ODT 10 MG Disintegrating Oral Tablet brand · RxCUI 668658 | 4 (1%) | 4 | 1 | 0 | 0 |
| Orapred ODT 15 MG Disintegrating Oral Tablet brand · RxCUI 647127 | 2 (1%) | 4 | 1 | 0 | 0 |
| Orapred ODT 30 MG Disintegrating Oral Tablet brand · RxCUI 668660 | 2 (1%) | 4 | 1 | 0 | 0 |
| Pred Forte 1 % Ophthalmic Suspension brand · RxCUI 1548724 | 1 (0%) | 1 | 0 | 0 | 0 |
Counts are formularies (of 328) in the CMS file that list the form, and how many of those apply prior authorization (PA), step therapy (ST) or a quantity limit (QL). Many plans share one formulary, so plan counts in a county will differ.
How to read drug coverage
Tier is the cost-sharing tier the plan assigned the drug in its CMS formulary filing; lower tiers usually cost less. PA = prior authorization, ST = step therapy (try another drug first), QL = quantity limit. Not on formulary means the plan did not list this exact form; the plan may cover another strength or a formulary exception may be possible. Cost sharing is the plan's initial-coverage amount for the tier as filed with CMS; the deductible, the $2,100 annual out-of-pocket cap, the $35 insulin cap and negotiated prices for selected drugs can change what you actually pay. Formularies change during the year; the plan's formulary document and Medicare.gov govern.
What the star rating under each Medicare Advantage plan means
What the star rating means. CMS rates every Medicare Advantage contract (the "H" number in the plan ID — all plans under it share the rating) on a 1-to-5 scale each October, from about 40 measures of care quality, member experience, complaints and appeals, customer service and, for plans with drug coverage, drug safety and pricing. The 2026 rating is largely based on performance measured in 2024.
5 Excellent4 Above average3 Average2 Below average1 Poor
Not rated means CMS published no overall rating — usually a contract too new to be measured or with too few members ("not enough data"); it is not a low score. A 5-star contract can be joined outside the normal enrollment windows (the 5-star Special Enrollment Period, Dec 8 – Nov 30). Medicare.gov flags contracts rated below 3 stars for three years running as low-performing. Stars describe the contract's past performance as CMS measured it; they are not a recommendation, and they do not tell you whether a plan's network, drugs or costs fit you.